Sociedad Americana de Hirudoterapia

Leech therapy for symptomatic treatment of knee osteoarthritis: results and implications of a pilot study

Research article published in Alternative therapies in health and medicine (2002)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Clinical trialEnsayos clínicosMichalsen A et al. · Alternative therapies in health and medicine, 2002

Abstract

CONTEXT: Leech therapy was a mainstay in conventional treatment for pain from antiquity until the mid-19th century. Its use is still widespread in traditional healing procedures in Asia, Africa, and Arabic countries. There is renewed interest in leech therapy in the field of complementary medicine and empirical evidence for specific benefit in knee osteoarthritis. OBJECTIVES: To determine the effect of leech therapy as an adjunctive treatment in painful knee osteoarthritis, to investigate the onset of action, to evaluate patients' acceptance of this treatment, and to investigate the side effects of the procedure. DESIGN: Observational, controlled, nonrandomized pilot-study. SETTING: Subjects were inpatients of an academic teaching hospital of the University of Essen, Department of Internal and Integrative Medicine, Essen, Germany. PATIENTS: 16 inpatients (mean age 69 +/- 9 years) with a confirmed diagnosis of osteoarthritis of the knee joint; 10 patients were treated with leeches and 6 served as controls. INTERVENTION: A single trial of 4 leeches (Hirudo medicinalis) applied topically at painful periarticular sites of the knee joint in the experimental group (n = 10). Both groups received conventional treatment for pain with the exclusion of nonsteroidal anti-inflammatory drugs. MAIN OUTCOME MEASURES: Self-reported general knee pain, assessed by visual analog scale for 10 days daily and in a follow-up after 28 days. Frequency of adverse effects also was recorded. RESULTS: Periarticular application of 4 leeches led to rapid relief of pain with sustained improvement after 4 weeks in the absence of major complications. CONCLUSION: Leech therapy may be an effective treatment for rapid reduction of pain associated with osteoarthritis of the knee. Its efficacy should be tested in larger randomized controlled trials with assessment of expectation bias.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeClinical TrialControlled Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAgedAnimalsAnti-Inflammatory Agents, Non-SteroidalFemaleHumansLeechesLeechingMaleMiddle AgedOsteoarthritis, KneePainPain Management

Resumen

Leech therapy for symptomatic treatment of knee osteoarthritis: results and implications of a pilot study.

Por qué esto importa para la hirudoterapia

Este estudio piloto observacional, controlado y no aleatorizado investigó la eficacia de una aplicación única de cuatro sanguijuelas Hirudo medicinalis en 10 pacientes hospitalizados con osteoartritis dolorosa de rodilla, en comparación con 6 controles con tratamiento convencional. Los investigadores hallaron que la terapia con sanguijuelas periarticular proporcionó un alivio del dolor rápido que se mantuvo durante un período de seguimiento de cuatro semanas sin complicaciones mayores. Estos resultados son directamente relevantes para la American Society of Hirudotherapy al aportar evidencia empírica preliminar que respalda el uso clínico de sanguijuelas medicinales para el manejo del dolor articular localizado. No obstante, el alcance está estrictamente limitado por un tamaño de muestra muy pequeño y la falta de aleatorización, lo que implica que el alivio del dolor observado podría estar fuertemente influido por el sesgo de expectativa y requiere validación en ensayos controlados de mayor tamaño.

Citación

Leech therapy for symptomatic treatment of knee osteoarthritis: results and implications of a pilot study

Michalsen A et al. · Alternative therapies in health and medicine, 2002

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.